NMPA Approval

Aflibercept Intravitreous Injection

Approval Number

国药准字SJ20255004

Registration Date

May 19, 2025

Previous Approval Numbers

国药准字SJ20180010

Drug Information

Generic Name

阿柏西普眼内注射溶液

Trade Name

艾力雅

Dosage Form

注射剂

Strength

114.3mg/mL (70µl含有8mg阿柏西普)

Drug Type

生物制品

Registration Date

May 19, 2025

Expiry Date

April 9, 2028

Company NameBAYER AG

Company Address

51368 Leverkusen, Germany

Company Address

1300 South Patterson Drive, Bloomington, Indiana, IN 47403, United States

Empowering clinical research with data-driven insights and AI-powered tools.